7208, In Multiple Disease Areas
29/07/2026 12:57
BRIEF-Processa Pharmaceuticals, Inc. Announces Acquisition Of Vidya Therapeutics, Inc. And Approximately $200 Million Concurrent Private Placement To Advance Btk Inhibitor, Vt-7208, In Multiple Disease Areas July 29 (Reuters) - Processa Pharmaceuticals Inc PCSA.O:
PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
Source text: ID:nGNX915dMp
Further company coverage: PCSA.O